Akzo Nobel N V S/Adr (AKZOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,830,605 | 1,408,894 | 1,637,520 | 1,527,720 | 1,362,931 |
| Marketable Securities | 341,683 | 178,547 | 286,810 | 354,010 | 68,620 |
| Receivables | 2,718,754 | 2,703,086 | 2,687,351 | 2,578,159 | 2,767,271 |
| Inventories | 1,729,911 | 1,862,294 | 1,784,713 | 1,941,785 | 1,952,115 |
| Other current assets | 236,463 | 162,316 | 145,028 | 177,004 | 176,282 |
| TOTAL | $6,857,416 | $6,315,136 | $6,541,421 | $6,578,678 | $6,327,219 |
| Non-Current Assets | |||||
| PPE Net | 2,306,925 | 2,296,216 | 2,158,106 | 2,073,485 | 2,129,580 |
| Investments And Advances | 0 | 0 | 0 | 0 | 210,592 |
| Intangibles | 4,297,057 | 4,381,423 | 4,416,866 | 4,290,259 | 4,365,639 |
| Other Non-Current Assets | 2,323,895 | 2,426,068 | 2,639,730 | 2,588,695 | 3,386,029 |
| TOTAL | $8,927,877 | $9,103,707 | $9,214,702 | $8,952,439 | $10,091,840 |
| Total Assets | $15,785,290 | $15,418,840 | $15,756,120 | $15,531,120 | $16,419,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,043,466 | 2,964,954 | 3,174,386 | 2,951,134 | 3,487,779 |
| Other current liabilities | 210,440 | 187,203 | 405,863 | 423,547 | 176,282 |
| TOTAL | $4,759,800 | $5,118,333 | $6,175,604 | $6,053,986 | $5,760,514 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,152,238 | 3,972,389 | 3,425,479 | 3,510,595 | 2,359,101 |
| Other Non-Current Liabilities | -40,730 | -54,105 | -44,373 | -27,394 | 918,086 |
| TOTAL | $5,569,882 | $5,089,116 | $4,660,384 | $4,685,359 | $3,990,596 |
| Total Liabilities | $10,329,680 | $10,207,450 | $10,835,990 | $10,739,350 | $9,751,110 |
| Shareholders' Equity | |||||
| Common Shares | 97,300 | 91,979 | 91,996 | 91,663 | 107,662 |
| Other shareholders' equity | 5,358,311 | 5,119,416 | 4,828,141 | 4,700,110 | 6,560,290 |
| TOTAL | $5,455,611 | $5,211,394 | $4,920,136 | $4,791,773 | $6,667,952 |
| Total Liabilities And Equity | $15,785,291 | $15,418,844 | $15,756,126 | $15,531,123 | $16,419,062 |